Axsome Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AXSM Nasdaq 2830 www.axsome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axsome Therapeutics, Inc.

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. - Jan 13th, 2025 9:15 pm
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue - Jan 13th, 2025 12:00 pm
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Profit Outlook - Jan 6th, 2025 1:21 pm
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results - Dec 31st, 2024 1:15 pm
Axsome Flashes A Bearish Signal On Mixed Results In Alzheimer's Agitation - Dec 30th, 2024 10:07 pm
Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation - Dec 30th, 2024 12:00 pm
Why Is Axsome (AXSM) Down 0.1% Since Last Earnings Report? - Dec 12th, 2024 4:30 pm
Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says - Nov 27th, 2024 6:23 pm
Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock ascends 5.5% this past week - Nov 26th, 2024 12:59 pm
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy - Nov 26th, 2024 12:00 pm
Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up - Nov 13th, 2024 4:08 pm
Q3 2024 Axsome Therapeutics Inc Earnings Call - Nov 13th, 2024 8:27 am
Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript - Nov 12th, 2024 8:15 pm
Axsome Hits 52-Week High After Surging Nearly 5%--FDA Milestones Could Fuel Even Bigger Gains - Nov 12th, 2024 5:42 pm
Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Nov 12th, 2024 12:00 pm
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024 - Nov 8th, 2024 12:00 pm
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for - Nov 5th, 2024 3:00 pm
Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024 - Oct 29th, 2024 11:00 am
3 Bargain Stocks to Buy in a Market That's Priced for Perfection - Oct 19th, 2024 11:30 am
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 - Oct 15th, 2024 11:00 am